
The promise of personalised medicine is not for everyone
Daniel R. Weinberger, Johns Hopkins University Could your medical treatment one day be tailored to…
Daniel R. Weinberger, Johns Hopkins University Could your medical treatment one day be tailored to…
About half of all drugs, ranging from morphine to penicillin, come from compounds that are…
By Ian Olver AM for oncologynews.com.au The term translational research is broad but most often…
“You don’t exactly want your tumour to take home and stick on your mantelpiece -…
By Professor Ian Olver AM for oncologynews.com.au. The control of non-communicable diseases is an emerging problem…
Led by Jean-Christophe Marine (VIB-KU Leuven), a team of researchers has tracked down the cellular…
A new Sydney conference will focus on improving collaboration across phase one clinical trials in…
Of the more than 3 million people with breast cancer in the United Stated, about…
Cancer evolution can lead to the emergence of drug resistance, so the ICR and The…
Scientists have identified for the first time the ‘cell of origin’ – in other words,…